{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:58:14Z","timestamp":1760731094094},"publisher-location":"Berlin, Heidelberg","reference-count":23,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783662586167"},{"type":"electronic","value":"9783662586174"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/8904_2018_129","type":"book-chapter","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T04:42:36Z","timestamp":1534394556000},"page":"93-101","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Enzyme Replacement Therapy During Pregnancy in Fabry Patients"],"prefix":"10.1007","author":[{"given":"Christoffer V.","family":"Madsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Ils\u00f8","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rikke","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5se K.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"key":"129_CR1","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1073\/pnas.85.11.3903","volume":"85","author":"DF Bishop","year":"1988","unstructured":"Bishop DF, Kornreich R, Desnick RJ (1988) Structural organization of the human a-galactosidase A gene: further evidence for the absence of a 3\u2032 untranslated region. Proc Natl Acad Sci U S A 85:3903\u20133907","journal-title":"Proc Natl Acad Sci U S A"},{"key":"129_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.placenta.2010.02.004","volume":"31","author":"MG Bouwman","year":"2010","unstructured":"Bouwman MG, Hollak CEM, van den Bergh Weerman MA et al (2010) Analysis of placental tissue in Fabry disease with and without enzyme replacement therapy. Placenta 31:344\u2013346. https:\/\/doi.org\/10.1016\/j.placenta.2010.02.004","journal-title":"Placenta"},{"key":"129_CR3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/clinchem\/13.7.565","volume":"14","author":"R Brady","year":"1967","unstructured":"Brady R (1967) Enzymatic abnormalities in diseases of sphingolipid metabolism. Clin Chem 14:565\u2013577","journal-title":"Clin Chem"},{"key":"129_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/cge.12613","volume":"89","author":"L Echevarria","year":"2016","unstructured":"Echevarria L, Benistan K, Toussaint A et al (2016) X-chromosome inactivation in female patients with Fabry disease. Clin Genet 89:44\u201354. https:\/\/doi.org\/10.1111\/cge.12613","journal-title":"Clin Genet"},{"key":"129_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ajog.2003.08.006","volume":"190","author":"Y Elstein","year":"2004","unstructured":"Elstein Y, Eisenberg V, Granovsky-Grisaru S et al (2004) Pregnancies in Gaucher disease: a 5-year study. Am J Obstet Gynecol 190:435\u2013441. https:\/\/doi.org\/10.1016\/j.ajog.2003.08.006","journal-title":"Am J Obstet Gynecol"},{"key":"129_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejmg.2009.12.004","volume":"53","author":"DP Germain","year":"2010","unstructured":"Germain DP, Bruneval P, Tran TC et al (2010) Uneventful pregnancy outcome after enzyme replacement therapy with agalsidase beta in a heterozygous female with Fabry disease: a case report. Eur J Med Genet 53:111\u2013112. https:\/\/doi.org\/10.1016\/j.ejmg.2009.12.004","journal-title":"Eur J Med Genet"},{"key":"129_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/8904_2014_384","volume":"21","author":"A Holmes","year":"2015","unstructured":"Holmes A, Laney D (2015) A retrospective survey studying the impact of Fabry disease on pregnancy. JIMD Rep 21:57\u201363. https:\/\/doi.org\/10.1007\/8904_2014_384","journal-title":"JIMD Rep"},{"key":"129_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejogrb.2009.01.007","volume":"144","author":"G Kalkum","year":"2009","unstructured":"Kalkum G, Macchiella D, Reinke J et al (2009) Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease. Eur J Obstet Gynecol Reprod Biol 144:92\u201393. https:\/\/doi.org\/10.1016\/j.ejogrb.2009.01.007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"129_CR9","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","volume":"167","author":"J Kint","year":"1970","unstructured":"Kint J (1970) Fabry disease: alpha-galactosidase deficiency. Science 167:1268\u20131269","journal-title":"Science"},{"key":"129_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jns.2017.01.068","volume":"375","author":"J K\u0142os","year":"2017","unstructured":"K\u0142os J, Kwa\u015bniak-Butowska M, S\u0142awek J (2017) Alglucosidase alfa therapy for Pompe disease in pregnancy \u2013 case report. J Neurol Sci 375:167\u2013169. https:\/\/doi.org\/10.1016\/j.jns.2017.01.068","journal-title":"J Neurol Sci"},{"key":"129_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD Macdermot","year":"2001","unstructured":"Macdermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769\u2013807","journal-title":"J Med Genet"},{"key":"129_CR12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3109\/14767050903580391","volume":"23","author":"E Parent","year":"2010","unstructured":"Parent E, Wax JR, Smith W et al (2010) Fabry disease complicating pregnancy. J Matern Fetal Neonatal Med 23:1253\u20131256. https:\/\/doi.org\/10.3109\/14767050903580391","journal-title":"J Matern Fetal Neonatal Med"},{"key":"129_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1447-0756.2009.01164.x","volume":"36","author":"JM Politei","year":"2010","unstructured":"Politei JM (2010) Treatment with agalsidase beta during pregnancy in Fabry disease. J Obstet Gynaecol Res 36:428\u2013429. https:\/\/doi.org\/10.1111\/j.1447-0756.2009.01164.x","journal-title":"J Obstet Gynaecol Res"},{"key":"129_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ymgmr.2016.08.002","volume":"8","author":"FJ Stewart","year":"2016","unstructured":"Stewart FJ, Bentley A, Burton BK et al (2016) Pregnancy in patients with mucopolysaccharidosis: a case series. Mol Genet Metab Rep 8:111\u2013115. https:\/\/doi.org\/10.1016\/j.ymgmr.2016.08.002","journal-title":"Mol Genet Metab Rep"},{"key":"129_CR15","first-page":"406","volume":"9","author":"ES Tasci","year":"2015","unstructured":"Tasci ES, Bicik Z (2015) Safe and successful treatment with agalsidase beta during pregnancy in Fabry disease. Iran J Kidney Dis 9:406\u2013408","journal-title":"Iran J Kidney Dis"},{"key":"129_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.humpath.2011.07.020","volume":"43","author":"BL Thurberg","year":"2012","unstructured":"Thurberg BL, Politei JM (2012) Histologic abnormalities of placental tissues in Fabry disease: a case report and review of the literature. Hum Pathol 43:610\u2013614. https:\/\/doi.org\/10.1016\/j.humpath.2011.07.020","journal-title":"Hum Pathol"},{"key":"129_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1447-0756.1985.tb00045.x","volume":"11","author":"O Tsutsumi","year":"1985","unstructured":"Tsutsumi O, Sato M, Sato K et al (1985) Early prenatal diagnosis of inborn error of metabolism: a case report of a fetus affected with Fabry\u2019s disease. Asia Oceania J Obstet Gynaecol 11:39\u201345","journal-title":"Asia Oceania J Obstet Gynaecol"},{"key":"129_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s10545-006-0196-0","volume":"29","author":"AC Vedder","year":"2006","unstructured":"Vedder AC, Strijland A, Weerman MAB et al (2006) Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis 29:106\u2013111. https:\/\/doi.org\/10.1007\/s10545-006-0196-0","journal-title":"J Inherit Metab Dis"},{"key":"129_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccl.2012.04.005","volume":"30","author":"AR Vest","year":"2012","unstructured":"Vest AR, Cho LS (2012) Hypertension in pregnancy. Cardiol Clin 30:407\u2013423. https:\/\/doi.org\/10.1016\/j.ccl.2012.04.005","journal-title":"Cardiol Clin"},{"key":"129_CR20","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1093\/ndt\/gfq044","volume":"25","author":"L Vinge","year":"2010","unstructured":"Vinge L, Lees GE, Nielsen R et al (2010) The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidney. Nephrol Dial Transplant 25:2458\u20132467. https:\/\/doi.org\/10.1093\/ndt\/gfq044","journal-title":"Nephrol Dial Transplant"},{"key":"129_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10545-005-0018-9","volume":"28","author":"S Wendt","year":"2005","unstructured":"Wendt S, Whybra C, Kampmann C et al (2005) Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa. J Inherit Metab Dis 28:787\u2013788. https:\/\/doi.org\/10.1007\/s10545-005-0018-9","journal-title":"J Inherit Metab Dis"},{"key":"129_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000060196","volume":"136","author":"C Whybra","year":"2001","unstructured":"Whybra C, Wendrich K, Ries M et al (2001) Clinical manifestation in female Fabry. Contrib Nephrol 136:245\u2013250","journal-title":"Contrib Nephrol"},{"key":"129_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","volume":"93","author":"WR Wilcox","year":"2008","unstructured":"Wilcox WR, Hopkin RJ, Ortiz A et al (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry registry. Mol Genet Metab 93:112\u2013128. https:\/\/doi.org\/10.1016\/j.ymgme.2007.09.013","journal-title":"Mol Genet Metab"}],"container-title":["JIMD Reports","JIMD Reports, Volume 44"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2018_129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T20:50:04Z","timestamp":1604782204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2018_129"}},"subtitle":["Review of Published Cases of Live Births and a New Case of a Severely Affected Female with Fabry Disease and Pre-eclampsia Complicating Pregnancy"],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783662586167","9783662586174"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/8904_2018_129","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"type":"print","value":"2192-8304"},{"type":"electronic","value":"2192-8312"}],"subject":[],"published":{"date-parts":[[2018]]}}}